Get the app
US › Healthcare

SINTX Technologies Inc (SINT)

US · Healthcare · Medical Devices

$1.56-3.70%
Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue
$452,000
Revenue YoY
+352.0%
Net profit
$-2.7M
EPS
$-0.75
EPS estimate
$-0.69
Net margin
-598.7%

EPS came in at -0.75 against a street estimate of -0.69 — a miss of 8.7%.

Key statistics

Market cap
$12.2M
Forward P/E
0.0
P/B
2.69
Book value
$0.73
EPS (TTM)
$-4.79
52-week high
$4.46
52-week low
$1.40
50-day MA
$1.80
200-day MA
$2.20
Beta
0.57

Analyst view

Analysts rate SINTX Technologies Inc a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $9.25.

Shareholding

Insiders
26.92%
Institutions
12.81%

Largest institutional holders

FundStake
Bleichroeder LP7.85%
Stonepine Capital Management Llc3.14%
Veracity Capital LLC1.15%
Citadel Advisors Llc0.48%
Geode Capital Management, LLC0.45%
Vanguard Fiduciary Trust Co0.35%
Vanguard Capital Management, LLC0.31%
State Street Corp0.20%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for SINTX Technologies Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-11-07.